-
BRIDGING THE GAP: BEHAVIORAL HEALTH PARITY AND SPECIALTY MENTAL HEALTH CARE IN TRICARE
Aug 11, 2026, 17:16 PM -
AGE OF DISEASE CAUSAL HUMAN PAPILLOMA VIRUS (HPV) INFECTION FOR OROPHARYNGEAL CANCER IN FINLAND AND POLAND: A MODELING STUDY
Aug 11, 2026, 17:16 PM -
COMPARING CLOSED-ENDED BIDDING WILLINGNESS-TO-PAY AND OPEN-ENDED SCENARIO-BASED METHODS FOR ESTIMATING THE INTANGIBLE COSTS OF EPILEPSY IN SAUDI ARABIA
Aug 11, 2026, 17:16 PM -
PUBLIC HEALTH AND ECONOMIC IMPACT OF STRATEGIES TO PROTECT INFANTS IN THE US AGAINST RSV
Aug 11, 2026, 17:16 PM -
REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND TREATMENT PATTERNS AMONG PATIENTS WITH HIDRADENITIS SUPPURATIVA IN CANADA USING AI-EXTRACTED DATA
Aug 11, 2026, 17:16 PM -
LEVERAGING A NATIONAL REAL-WORLD DATA ASSET LIBRARY TO CHARACTERISE CLINICAL RECOGNISED BUT UNDER-CATEGORISED CONDITIONS IN ELECTRONIC HEALTH RECORDS: A CASE STUDY OF NON-CYSTIC FIBROSIS BRONCHIECTASIS (NCFB) IN CHINA
Aug 11, 2026, 17:16 PM -
TECREAL STUDY: TECLISTAMAB OUTCOMES IN THE CONTEXT OF REAL-WORLD TREATMENT PATTERNS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
Aug 11, 2026, 17:16 PM -
PERFORMANCE AND SYSTEMIC CHALLENGES IN THE MANAGEMENT OF CARDIOVASCULAR DISEASES IN GREECE: A DELPHI CONSENSUS STUDY
Aug 11, 2026, 17:16 PM -
BURNOUT AND WORKPLACE SATISFACTION AMONG COMMUNITY PHARMACISTS DURING THE FIRST WAVE OF THE COVID-19 PANDEMIC IN HUNGARY: SCALE DEVELOPMENT AND A NATIONAL CROSS-SECTIONAL STUDY
Aug 11, 2026, 17:16 PM -
ASSESSING THE ENVIRONMENTAL BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SPAIN AND OPPORTUNITIES FOR EMISSION REDUCTION
Aug 11, 2026, 17:16 PM -
SUCCESS FACTORS FOR INDIRECT TREATMENT COMPARISONS IN GERMANY: AN AI-POWERED ANALYSIS
Aug 11, 2026, 17:16 PM -
PUBLIC PREFERENCES FOR A NET ZERO HEALTH CARE SERVICE
Aug 11, 2026, 17:16 PM -
ADO2DNET: A LIGHTWEIGHT DEEP LEARNING FRAMEWORK FOR DISTINGUISHING AUTISM SPECTRUM DISORDER (ASD) FROM ATTENTION DEFICIT AND HYPERACTIVITY DISORDER (ADHD) IN ADOLESCENT COHORTS BASED ON RESTING-STATE FMRI IMAGES
Aug 11, 2026, 17:16 PM -
CHINA'S PHARMACEUTICAL INNOVATION: DOMESTIC AND GLOBAL MARKETING AUTHORIZATION, 2015-2025
Aug 11, 2026, 17:16 PM -
SOCIETY-LEVEL IMPACT OF OCRELIZUMAB IN THE TREATMENT OF MULTIPLE SCLEROSIS IN ALGERIA
Aug 11, 2026, 17:16 PM -
AN AI ENABLED DIGITAL TWIN FOR SIMULATING ANTI-VEGF TREATMENT STRATEGIES IN REAL-WORLD NAMD CARE
Aug 11, 2026, 17:16 PM -
SURROGATE-TO-THRESHOLD PRICING: BENCHMARKING THE IGA NEPHROPATHY CASCADE AGAINST A DIALYSIS-REVEALED WILLINGNESS-TO-PAY
Aug 11, 2026, 17:16 PM -
BEYOND PICO PREDICTION: A SYSTEMATIC FRAMEWORK FOR EVIDENCE GAP ANALYSIS AND STRATEGIC PRIORITIZATION FOR EUROPEAN UNION JOINT CLINICAL ASSESSMENT (EU JCA) READINESS
Aug 11, 2026, 17:16 PM -
INDIRECT TREATMENT COMPARISON (ITC) OF AUMOLERTINIB VS. OSIMERTINIB IN ADVANCED OR METASTATIC EGFR MUTATED NON-SMALL CELL LUNG CANCER (NSCLC) IN FIRST-LINE AND PREVIOUSLY TREATED SETTINGS
Aug 11, 2026, 17:16 PM -
BEYOND OBESITY: CAN COMORBIDITY INDICATION EXPANSION UNLOCK PAYER ACCESS WHERE OBESITY IS RESTRICTED OR REFUSED?
Aug 11, 2026, 17:16 PM
